Skip to content
Clinical Trials – home

Institut Fuer Forschung Und Innovation In Der Augenchirurgie

Research site

Austria Heinrich-Collin-Strasse 30, Penzing, 1140 Vienna, Austria

  • 2 trials recruiting
  • Age-related macular degeneration · Diabetic retinal oedema · Dry age-related macular degeneration
  • Adult patients

About Specializations

Institut Fuer Forschung Und Innovation In Der Augenchirurgie in Vienna, Austria specialises in clinical trials of conditions such as Age-related macular degeneration, Diabetic retinal oedema, Dry age-related macular degeneration, Endocrine ophthalmopathy, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases and Ocular Physiological Phenomena

The research at Institut Fuer Forschung Und Innovation In Der Augenchirurgie focuses on ophthalmology and related visual function, with studies centered on major eye diseases and how they affect sight and eye health. The trials are designed to assess new treatment options and compare them with current care, while also looking at outcomes that matter to vision and daily function.

  • Diabetic Macular Edema and treatment effectiveness in preserving visual acuity
  • Atrophic Age-related Macular Degeneration and slowing the progression of geographic atrophy
  • Thyroid Eye Disease and evaluating symptom control with a new therapy

This site in Vienna is contributing to clinical research that aims to improve how serious retinal and inflammatory eye conditions are managed, with a clear emphasis on better vision outcomes and more effective care options.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Heinrich-Collin-Strasse 30, Penzing1140 ViennaAustria
Recruiting now
2 trials
Conditions studied
6

More sites in ViennaAustria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Xelafaslatide
  • Sponsor:ONL Therapeutics Inc.

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Macular oedema+1

Not recruiting

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.